Quality of life in brain metastases radiation trials: a literature review

BACKGROUND: An estimated 20%–40% of cancer patients will develop brain metastases. Whole-brain radiotherapy (wbrt) is the standard treatment for patients with brain metastases. Although wbrt can reduce neurologic symptoms, the median survival following wbrt is between 3 and 6 months. Given this limi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wong, J., Hird, A., Kirou–Mauro, A., Napolskikh, J., Chow, E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2008
Témata:
E-Manuscript Article Summary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582512/
https://ncbi.nlm.nih.gov/pubmed/19008990
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky